Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem.

Chebib, Nader; Cottin, Vincent; Taharo-Ag-Ralissoum, Martine; Chuzeville, Michel; Mornex, Jean-François

Chebib, Nader; Cottin, Vincent; Taharo-Ag-Ralissoum, Martine; Chuzeville, Michel; Mornex, Jean-François.

Afiliação

Chebib N; 1 Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France.
Cottin V; 1 Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France.
Taharo-Ag-Ralissoum M; 2 Claude Bernard Lyon 1 University, University of Lyon, Lyon, France.
Chuzeville M; 1 Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France.
Mornex JF; 3 Hospices Civils de Lyon, Hôpital Edouard Herriot, Cardiogeriatrics Department, Lyon, France.

Pulm Circ ; 8(1): 2045893217753352, 2018.

Article em En | MEDLINE | ID: mdl-29283031

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pulm Circ Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google